Active Ingredient
Sennosides 8.6 mg
The following Structured Product Label (SPL) was submitted to the FDA by Marc Glassman, Inc. for the product Senna-lax (NDC 68998-373). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Sennosides 8.6 mg
Laxative
laxative products for more than one week unless directed by a doctor
ask a health professional before use.
In case of accidental overdose, contact a doctor or Poison Control Center (1-800-222-1222) right away.
| Age | Starting dosage | Maximum dosage |
| Adults and children over 12 years | 2 tablets once a day | 4 tablets twice a day |
| Children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| Children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| Children under 2 years | consult a doctor | consult a doctor |
■ store at 20°C-25°C (68°F-77°F)
■ do not use if safety seal under cap is torn or missing
■ Calcium content: 50 mg per tablet
croscarmellose sodium, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide
* Please review the disclaimer below.